Search
Search Funnelback University
- Refined by:
- Date: 2024
- Format: pdf
41 -
44 of
44
search results for download |u:www.enterprise.cam.ac.uk
Fully-matching results
-
Microparticle production platform technology (DropShell)
https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=2816228 Jul 2024: Microparticle production platform technology(DropShell). Background. Engineered microparticles are ubiquitous in many commercial products, fromagritech to nutraceuticals and cosmetics. In the pharmaceutical industry,controlled encapsulation and -
LGR5 monoclonal antibody for cancer immunotherapy
https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=2357228 Jul 2024: LGR5 monoclonal antibody for cancerimmunotherapy. Background. In 2020, there were 1.9 million new cases of colorectal cancer, which is the 3rdmost common cancer worldwide. Liver cancer and Leukaemia are the 6th and13th most common cancer types, -
MAT2A inhibitors to treat BK polyomavirus disease
https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=2810228 Jul 2024: MAT2A inhibitors to treat BK polyomavirusdisease. Background. BKPyV is a pervasive human pathogen which resides within the reno-urinarytract in 80-90% of the population. It is asymptomatic in healthy individuals;however, it poses a significant -
Electronic nose
https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=2628328 Jul 2024: Electronic nose. Background. This technology “represents a considerable advance in the state-of-the-art…Highly original and building from a sparse amount of previous research”-Prof Krishna Persaud, e-nose pioneer. What would we recognise if
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.